Medicines Patent Pool
latest news & developments
SA wants to make its own six-monthly HIV prevention jabs by 2027. But there’s a hitch
None of the companies that will be involved have a licence from the inventor of Lenacapavir, Gilead Sciences, to make the jab
Sharing the secrets of making a Covid-19 vaccine isn’t enough. Here’s why
For all the excitement generated by the news of an mRNA vaccine hub being established in South Africa, the country is still going to need help making Covid-19 jabs